JCO:左肺癌4L淋巴结清扫的临床意义

2018-08-28 MedSci MedSci原创

JCO近期发表了一篇文章,研究左肺癌4L淋巴结清扫对预后的影响以及4L淋巴结转移的相关危险因素。

JCO近期发表了一篇文章,研究左肺癌4L淋巴结清扫对预后的影响以及4L淋巴结转移的相关危险因素。

作者收集了2005年至2009年间原发左肺癌且接受手术切除的657例患者数据。其中139例患者进行了4L淋巴结清扫(4L D+组),另外518例患者未接受4L淋巴结清扫(4L D-组)。研究终点为无进展生存和总生存情况。研究结果表明,4L站淋巴结转移率为20.9%,显着高于7站(14%)和9站(9.8%)。单因素分析中4L站淋巴结转移与其它站淋巴结转移相关,但在logistic分析中只有10站淋巴结转移是4L站淋巴结转移的独立危险因素。4L站淋巴结清扫组患者生存显着优于未清扫组。调整了潜在混杂因素后,4L淋巴结清扫依然是无病生存和总生存独立有利因素。

文章最后认为,左肺癌4L站淋巴结转移并不少见,4L淋巴结清扫与患者预后改善有关。

原始出处:
Ya-Nan Wang,Shuang Yao,et al.Clinical Significance of 4L Lymph Node Dissection in Left Lung Cancer.JCO.August 2018 doi:10.1200/JCO.2018.78.7101

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1973346, encodeId=9ddf19e334631, content=<a href='/topic/show?id=b7d8660203a' target=_blank style='color:#2F92EE;'>#淋巴结清扫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66020, encryptionId=b7d8660203a, topicName=淋巴结清扫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Wed Sep 19 15:30:00 CST 2018, time=2018-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891541, encodeId=ec431891541ed, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Thu Jan 03 01:30:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293043, encodeId=f2071293043e9, content=<a href='/topic/show?id=df626600877' target=_blank style='color:#2F92EE;'>#淋巴结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66008, encryptionId=df626600877, topicName=淋巴结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Thu Aug 30 10:30:00 CST 2018, time=2018-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591052, encodeId=ce611591052d5, content=<a href='/topic/show?id=874a48140ae' target=_blank style='color:#2F92EE;'>#左肺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48140, encryptionId=874a48140ae, topicName=左肺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de2117898903, createdName=amyloid, createdTime=Thu Aug 30 10:30:00 CST 2018, time=2018-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341546, encodeId=37c134154609, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/iaAVWEsIJUkA1ITy3uL0lhHUhyaJibWgFtH4KbJuaLbY2WUK33jgCFyoZ8Eqx7eE7hCuZhytc1C5GRrfjVXN8lYg/0, createdBy=fcb82149579, createdName=183****7028, createdTime=Wed Aug 29 01:39:16 CST 2018, time=2018-08-29, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1973346, encodeId=9ddf19e334631, content=<a href='/topic/show?id=b7d8660203a' target=_blank style='color:#2F92EE;'>#淋巴结清扫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66020, encryptionId=b7d8660203a, topicName=淋巴结清扫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Wed Sep 19 15:30:00 CST 2018, time=2018-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891541, encodeId=ec431891541ed, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Thu Jan 03 01:30:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293043, encodeId=f2071293043e9, content=<a href='/topic/show?id=df626600877' target=_blank style='color:#2F92EE;'>#淋巴结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66008, encryptionId=df626600877, topicName=淋巴结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Thu Aug 30 10:30:00 CST 2018, time=2018-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591052, encodeId=ce611591052d5, content=<a href='/topic/show?id=874a48140ae' target=_blank style='color:#2F92EE;'>#左肺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48140, encryptionId=874a48140ae, topicName=左肺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de2117898903, createdName=amyloid, createdTime=Thu Aug 30 10:30:00 CST 2018, time=2018-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341546, encodeId=37c134154609, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/iaAVWEsIJUkA1ITy3uL0lhHUhyaJibWgFtH4KbJuaLbY2WUK33jgCFyoZ8Eqx7eE7hCuZhytc1C5GRrfjVXN8lYg/0, createdBy=fcb82149579, createdName=183****7028, createdTime=Wed Aug 29 01:39:16 CST 2018, time=2018-08-29, status=1, ipAttribution=)]
    2019-01-03 lidong40
  3. [GetPortalCommentsPageByObjectIdResponse(id=1973346, encodeId=9ddf19e334631, content=<a href='/topic/show?id=b7d8660203a' target=_blank style='color:#2F92EE;'>#淋巴结清扫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66020, encryptionId=b7d8660203a, topicName=淋巴结清扫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Wed Sep 19 15:30:00 CST 2018, time=2018-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891541, encodeId=ec431891541ed, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Thu Jan 03 01:30:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293043, encodeId=f2071293043e9, content=<a href='/topic/show?id=df626600877' target=_blank style='color:#2F92EE;'>#淋巴结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66008, encryptionId=df626600877, topicName=淋巴结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Thu Aug 30 10:30:00 CST 2018, time=2018-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591052, encodeId=ce611591052d5, content=<a href='/topic/show?id=874a48140ae' target=_blank style='color:#2F92EE;'>#左肺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48140, encryptionId=874a48140ae, topicName=左肺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de2117898903, createdName=amyloid, createdTime=Thu Aug 30 10:30:00 CST 2018, time=2018-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341546, encodeId=37c134154609, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/iaAVWEsIJUkA1ITy3uL0lhHUhyaJibWgFtH4KbJuaLbY2WUK33jgCFyoZ8Eqx7eE7hCuZhytc1C5GRrfjVXN8lYg/0, createdBy=fcb82149579, createdName=183****7028, createdTime=Wed Aug 29 01:39:16 CST 2018, time=2018-08-29, status=1, ipAttribution=)]
    2018-08-30 sodoo
  4. [GetPortalCommentsPageByObjectIdResponse(id=1973346, encodeId=9ddf19e334631, content=<a href='/topic/show?id=b7d8660203a' target=_blank style='color:#2F92EE;'>#淋巴结清扫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66020, encryptionId=b7d8660203a, topicName=淋巴结清扫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Wed Sep 19 15:30:00 CST 2018, time=2018-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891541, encodeId=ec431891541ed, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Thu Jan 03 01:30:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293043, encodeId=f2071293043e9, content=<a href='/topic/show?id=df626600877' target=_blank style='color:#2F92EE;'>#淋巴结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66008, encryptionId=df626600877, topicName=淋巴结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Thu Aug 30 10:30:00 CST 2018, time=2018-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591052, encodeId=ce611591052d5, content=<a href='/topic/show?id=874a48140ae' target=_blank style='color:#2F92EE;'>#左肺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48140, encryptionId=874a48140ae, topicName=左肺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de2117898903, createdName=amyloid, createdTime=Thu Aug 30 10:30:00 CST 2018, time=2018-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341546, encodeId=37c134154609, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/iaAVWEsIJUkA1ITy3uL0lhHUhyaJibWgFtH4KbJuaLbY2WUK33jgCFyoZ8Eqx7eE7hCuZhytc1C5GRrfjVXN8lYg/0, createdBy=fcb82149579, createdName=183****7028, createdTime=Wed Aug 29 01:39:16 CST 2018, time=2018-08-29, status=1, ipAttribution=)]
    2018-08-30 amyloid
  5. [GetPortalCommentsPageByObjectIdResponse(id=1973346, encodeId=9ddf19e334631, content=<a href='/topic/show?id=b7d8660203a' target=_blank style='color:#2F92EE;'>#淋巴结清扫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66020, encryptionId=b7d8660203a, topicName=淋巴结清扫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Wed Sep 19 15:30:00 CST 2018, time=2018-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891541, encodeId=ec431891541ed, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Thu Jan 03 01:30:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293043, encodeId=f2071293043e9, content=<a href='/topic/show?id=df626600877' target=_blank style='color:#2F92EE;'>#淋巴结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66008, encryptionId=df626600877, topicName=淋巴结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Thu Aug 30 10:30:00 CST 2018, time=2018-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591052, encodeId=ce611591052d5, content=<a href='/topic/show?id=874a48140ae' target=_blank style='color:#2F92EE;'>#左肺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48140, encryptionId=874a48140ae, topicName=左肺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de2117898903, createdName=amyloid, createdTime=Thu Aug 30 10:30:00 CST 2018, time=2018-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341546, encodeId=37c134154609, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/iaAVWEsIJUkA1ITy3uL0lhHUhyaJibWgFtH4KbJuaLbY2WUK33jgCFyoZ8Eqx7eE7hCuZhytc1C5GRrfjVXN8lYg/0, createdBy=fcb82149579, createdName=183****7028, createdTime=Wed Aug 29 01:39:16 CST 2018, time=2018-08-29, status=1, ipAttribution=)]
    2018-08-29 183****7028

    学习

    0